Morphometric analysis of corneal endothelium after intravitreal ranibizumab (Lucentis®) in age-related macular degeneration treatment
Análisis morfométrico del endotelio corneal tras ranibizumab intravítreo en la degeneración macular asociada a la edad
J. Benítez-Herreros, C. Pérez-Rico
, M.A. Teus, Y. Gómez-San Gil, M. Castro-Rebollo
Corresponding author
Servicio de Oftalmología, Hospital Universitario Príncipe de Asturias, Universidad de Alcalá, Madrid, Spain
Read
298
Timeswas read the article
168
Total PDF
130
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 10 | 0 | 1 | 1 |
| 2025 9 | 0 | 3 | 3 |
| 2025 8 | 0 | 5 | 5 |
| 2025 7 | 0 | 3 | 3 |
| 2025 4 | 0 | 1 | 1 |
| 2025 3 | 0 | 1 | 1 |
| 2025 1 | 0 | 1 | 1 |
| 2024 12 | 0 | 1 | 1 |
| 2024 11 | 0 | 1 | 1 |
| 2024 8 | 0 | 2 | 2 |
| 2024 7 | 0 | 2 | 2 |
| 2024 4 | 0 | 4 | 4 |
| 2023 12 | 0 | 2 | 2 |
| 2023 10 | 0 | 3 | 3 |
| 2023 9 | 0 | 1 | 1 |
| 2023 8 | 0 | 1 | 1 |
| 2023 7 | 0 | 7 | 7 |
| 2023 5 | 0 | 2 | 2 |
| 2023 4 | 0 | 4 | 4 |
| 2023 2 | 0 | 3 | 3 |
| 2023 1 | 0 | 1 | 1 |
| 2022 12 | 0 | 4 | 4 |
| 2022 11 | 0 | 1 | 1 |
| 2022 10 | 0 | 3 | 3 |
| 2022 7 | 0 | 1 | 1 |
| 2022 6 | 0 | 2 | 2 |
| 2022 5 | 0 | 2 | 2 |
| 2022 4 | 0 | 4 | 4 |
| 2022 3 | 0 | 4 | 4 |
| 2022 2 | 0 | 4 | 4 |
| 2022 1 | 0 | 3 | 3 |
| 2021 12 | 0 | 1 | 1 |
| 2021 11 | 0 | 1 | 1 |
| 2021 9 | 0 | 1 | 1 |
| 2021 8 | 0 | 2 | 2 |
| 2021 7 | 0 | 2 | 2 |
| 2021 2 | 0 | 2 | 2 |
| 2021 1 | 0 | 2 | 2 |
| 2020 11 | 0 | 1 | 1 |
| 2020 8 | 0 | 1 | 1 |
| 2020 6 | 0 | 1 | 1 |
| 2020 3 | 0 | 2 | 2 |
| 2019 12 | 0 | 4 | 4 |
| 2019 11 | 0 | 3 | 3 |
| 2019 10 | 0 | 1 | 1 |
| 2019 5 | 0 | 23 | 23 |
| 2018 2 | 2 | 5 | 7 |
| 2018 1 | 1 | 2 | 3 |
| 2017 11 | 3 | 3 | 6 |
| 2017 10 | 5 | 5 | 10 |
| 2017 9 | 6 | 6 | 12 |
| 2017 8 | 1 | 0 | 1 |
| 2017 7 | 2 | 2 | 4 |
| 2017 6 | 1 | 2 | 3 |
| 2017 5 | 6 | 2 | 8 |
| 2017 4 | 13 | 2 | 15 |
| 2017 3 | 6 | 2 | 8 |
| 2017 2 | 10 | 0 | 10 |
| 2017 1 | 2 | 0 | 2 |
| 2016 12 | 11 | 3 | 14 |
| 2016 11 | 18 | 2 | 20 |
| 2016 10 | 19 | 4 | 23 |
| 2016 9 | 11 | 1 | 12 |
| 2016 8 | 10 | 3 | 13 |
| 2016 7 | 3 | 0 | 3 |
Show all
